IonQ's specialized quantum-computing hardware arrangements are reflected in the sales line. Revenue for the three months ended June 30 reached $80.0 million, up from $20.7 million in the comparable period, a 286.8% jump.
The company says the increase came from progress on hardware arrangements and revenue added through acquisitions.
"The increase was primarily driven by progress on our arrangements to build specialized quantum computing hardware, as well as increased revenue as a result of acquisitions."
IonQ, 10-Q, Aug. 10, 2026
The complication is sitting below the business itself. IonQ reported a $1.9 billion net loss for the three months, compared with a $176.8 million loss a year earlier. A $1.649 billion loss from revaluing warrant liabilities did most of the damage.
"The change in the fair value of the warrant liabilities was primarily due to the mark-to-market loss recognized on the Series A and Series B warrants, driven by changes in our stock price."
IonQ, 10-Q, Aug. 10, 2026
That is an accounting hit tied to the stock price, not a $1.649 billion operating expense for building quantum computers. The six-month cash-flow disclosure treats warrant mark-to-market activity among the non-cash adjustments. Reported earnings therefore became a very noisy measure of what the operating business did in the period.
The filing still leaves plenty of operating exposure to measure. Diluted shares rose 46.5% from the comparable period, while research and development spending increased 55.4%. Cash stood at $1.2 billion, up from $140.1 million a year earlier, but IonQ used $254.8 million in operating cash during the six months ended June 30.
Working capital also expanded faster than the headline sales growth. Accounts receivable rose 454.1%, and inventory increased 186.2%. IonQ does not say why those balances changed. Capex rose 430.8%, while free-cash-flow margin was negative 188.9%, putting the cash balance and the pace of investment in the same frame.
The contrast is not new in the company's own annual record: revenue reached $130.0M in 2025 after growing 201.9%, while the latest annual operating margin was -487.4%. The current filing adds scale to that pattern, but not yet a clean link between sales growth and operating cash generation.
The valuation makes that distinction relevant. IonQ's enterprise value was $11.4B, or 87.9 times annual sales. At that kind of sales multiple, the argument is largely about how quickly revenue can compound and how much of it can eventually survive the research, hardware, acquisition, compensation, and warrant lines.
IonQ's next quarterly report will leave one factual question on the table: how its operating cash use and warrant liabilities compare after this period's mark-to-market swing.
IonQ's Aug. 10 10-Q attributes the warrant loss to Series A and Series B mark-to-market changes driven by its stock price.